Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
A retrospective study on the use of ivabradine at a medical centre in northern taiwan
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: CHEN, Yenhua (Cathay general hospital)
- Co-author(s): Yen-Hua Chen: Cathay general hospital, Taipei, Taiwan, Province of China
Ya-Wen Yang: Cathay general hospital, Taipei, Taiwan, Province of China
Wan-Tsui Huang: Cathay general hospital, Taipei, Taiwan, Province of China;, School of Pharmacy, Taipei Medical University, Taipei, Taiwan, Province of China
BackgroundIvabradine, a novel heart rate lowering medicine for chronic heart failure has been approved at the medical centre in northern Taiwan in 2016 May 1st.
MethodsOutpatients who had been prescribed ivabradine from 2016 May 1st to 2017 Oct 31st were included. Efficacy evaluation included heart rate (HR) decrease and left ventricular ejection.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019